| 000 | 01823 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515164236.0 | ||
| 264 | 0 | _c20090421 | |
| 008 | 200904s 0 0 eng d | ||
| 022 | _a1097-6744 | ||
| 024 | 7 |
_a10.1016/j.ahj.2008.08.031 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMak, Koon-Hou | |
| 245 | 0 | 0 |
_aEthnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study. _h[electronic resource] |
| 260 |
_bAmerican heart journal _cApr 2009 |
||
| 300 |
_a658-65 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAtherosclerosis _xdrug therapy |
| 650 | 0 | 4 |
_aCause of Death _xtrends |
| 650 | 0 | 4 | _aClopidogrel |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aEthnicity |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHemorrhage _xethnology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Ischemia _xethnology |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aStroke _xethnology |
| 650 | 0 | 4 |
_aTiclopidine _xadverse effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aBhatt, Deepak L | |
| 700 | 1 | _aShao, Mingyuan | |
| 700 | 1 | _aHankey, Graeme J | |
| 700 | 1 | _aEaston, J Donald | |
| 700 | 1 | _aFox, Keith A A | |
| 700 | 1 | _aTopol, Eric J | |
| 773 | 0 |
_tAmerican heart journal _gvol. 157 _gno. 4 _gp. 658-65 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ahj.2008.08.031 _zAvailable from publisher's website |
| 999 |
_c18768540 _d18768540 |
||